期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 22, 期 19, 页码 6229-6232出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2012.08.012
关键词
Metallo-beta-lactamase; Inhibitor; Rational design; Molecular modeling
资金
- National Institute of Allergy and Infectious Disease (NIAID/NIH) [R21AI090190]
- NIAID/NIH [R01AI32956]
- NIH/NIDDK [T90DK070109]
Bacterial resistance to beta-lactam antibiotics caused by class B metallo-beta-lactamases (MBL), especially for certain hospital-acquired, Gram-negative pathogens, poses a significant threat to public health. We report several 2-substituted 4,5-dihydrothiazole-4-carboxylic acids to be novel MBL inhibitors. Structure activity relationship (SAR) and molecular modeling studies were performed and implications for further inhibitor design are discussed. (C) 2012 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据